← Browse by Condition
Medical Condition
autism spectrum disorder asd
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 3
Autism spectrum disorder (ASD) trials target core symptoms (social communication, restricted/repetitive behaviors) as well as co-occurring conditions including anxiety, sleep disturbance, and gastrointestinal problems. The heterogeneity of ASD β€” driven by hundreds of genetic variants β€” has driven interest in genotype-stratified trials that enroll specific genetic subtypes (SHANK3, CHD8, FMR1).
Trials evaluate oxytocin nasal spray, vasopressin receptor modulators, mGluR5 antagonists in fragile X, bumetanide (GABA modulator), transcranial magnetic stimulation, and early intensive behavioral interventions. Biomarkers including EEG connectivity measures and eye-tracking are being validated as objective outcome measures.
Frequently Asked Questions — autism spectrum disorder asd Clinical Trials
How many clinical trials are currently recruiting for autism spectrum disorder asd?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for autism spectrum disorder asd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for autism spectrum disorder asd?
autism spectrum disorder asd research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a autism spectrum disorder asd clinical trial?
Eligibility criteria for autism spectrum disorder asd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06878326
Recruiting
Enrollment
90 pts
Location
Hong Kong
Sponsor
The Hong Kong Polytechnic Univ...
NCT07450443 Phase 2, Phase 3
Recruiting
Enrollment
90 pts
Location
Italy
Sponsor
Fondazione I.R.C.C.S. Istituto...
NCT06925308
Recruiting
Enrollment
54 pts
Location
Netherlands
Sponsor
UMC Utrecht
NCT06880159
Recruiting
Enrollment
90 pts
Location
Hong Kong
Sponsor
The Hong Kong Polytechnic Univ...
NCT07064967
Recruiting
Enrollment
80 pts
Location
China
Sponsor
Guangzhou Women and Children's...
NCT05182697
Recruiting
Enrollment
60 pts
Location
Israel
Sponsor
Neurothera Labs Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology